Logo image
Benign multi-cystic peritoneal mesothelioma of the porta hepatis
Journal article   Open access   Peer reviewed

Benign multi-cystic peritoneal mesothelioma of the porta hepatis

Hassan Aziz, Michelle Hao, Alam Merchant, Daniel Alfson, Chris Foran and M. Raashid Sheikh
International journal of surgery case reports, Vol.74, pp.218-221
01/01/2020
DOI: 10.1016/j.ijscr.2020.08.047
PMCID: PMC7481495
PMID: 32892123
url
https://doi.org/10.1016/j.ijscr.2020.08.047View
Published (Version of record) Open Access

Abstract

INTRODUCTION: Our case report describes a patient where multiple laparoscopies five years from initial presentation of symptoms were performed prior to laparotomy for benign multi-cystic peritoneal mesothelioma (BMPM), which has not been documented. PRESENTATION: A 61-year-old woman presented with years of chronic abdominal pain. Computerized tomography (CT) demonstrated a multi-cystic mass near the porta hepatis, and ultrasound was concerning for contained gallbladder perforation. Fine needle aspiration (FNA) demonstrated benign ductal epithelial cells in a background of mucin and bile without the presence of malignant cells. During laparotomy, a cystic mass attached to the porta hepatis seen emanating from the small bowel mesentery, and additional small cystic lesions through the abdomen were removed. The specimen, measuring 26 x 18 x 8 cm, showed multi-loculated cysts filled with serous fluid. DISCUSSION: BMPM is a rare neoplasm of mesothelioma cells originating from serosa of viscous organs. BMPMs appear as cystic structures with thin walls containing mutinous/gelatinous fluid. Microscopic features include a lack of invasion and no increased cellularity in the stroma, with or without inflammation (Myers & Babiker, 2018). It is postulated to be either a reactive or neoplastic process. There is no gold-standard treatment for BMPM. Our case is unique in the sense that our patient required several surgical biopsies before final diagnosis could be made. CONCLUSION: This case highlights the difficulty of diagnosing BMPM and differentiating it from malignant diseases that can present similarly and can be associated with significantly worse prognosis. Defined management strategies have yet to be demonstrated. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Life Sciences & Biomedicine Science & Technology Surgery

Details

Metrics

Logo image